University of Giessen, official name Justus Liebig University Giessen, is a large public research university in Giessen, Hesse, Germany. It is named after its most famous faculty member, Justus von Liebig, the founder of modern agricultural chemistry and inventor of artificial fertiliser.

During the past decade, Justus-Liebig-University Giessen conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Justus-Liebig-University Giessen" #1 sponsor was "University of Giessen" with 3 trials, followed by "Actelion" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 1 trials sponsored and "AgNovos Healthcare, LLC" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Justus-Liebig-University Giessen" #1 collaborator was "University of Giessen" with 2 trials as a collaborator, "Activaero GmbH" with 1 trials as a collaborator, "Avania" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator and "BioClinica, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Justus-Liebig-University Giessen" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Adverse Reaction to Vaccine" (1 trials), "Anemia" (1 trials), "Angina Pectoris" (1 trials) and "Angina Pectoris, Stable" (1 trials). Many other conditions were trialed in "Justus-Liebig-University Giessen" in a lesser frequency.

Most popular intervention types in "Justus-Liebig-University Giessen" are "Drug" (8 trials), "Device" (5 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ACT-064992 (macitentan)" (1 trials), "ACURATE TA™ Transapical Aortic Bioprosthesis" (1 trials), "AGN1 LOEP treatment" (1 trials) and "AZD1222" (1 trials). Other intervention names were less common.

The vast majority of trials in "Justus-Liebig-University Giessen" are 18 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Justus-Liebig-University Giessen". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Justus-Liebig-University Giessen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Justus-Liebig-University Giessen, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Justus-Liebig-University Giessen has several departments that took part in Clinical trials: "Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology" - 5 trials, "Klinik der Justus-Liebig-Universität; Innere Medizin" - 4 trials, "Department of Internal Medicine, University of Giessen" - 4 trials, "Department of Sports Medicine, Institute of Sports Science, University of Giessen" - 2 trials, "Justus-Liebig Universität - Department of Ophthalmology" - 2 trials, "Clinical Research Unit" - 2 trials